How Big Is the Arterial Blood Sampling System Market? Size, Share & Forecast 2033

Arterial Blood Sampling System by Application (Hospitals, Clinics, Blood Banks, Diagnostic Laboratories, Others), by Types (Blood Collection Tubes, Needles, Vacuum Blood Collection System, Microfluidic System, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $850 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $850 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Arterial Blood Sampling System Market Overview

Arterial Blood Sampling Systems are medical devices used to obtain arterial blood specimens for gas analysis, critical‑care diagnostics, and therapeutic monitoring. Their precision and safety are essential for managing life‑threatening conditions such as respiratory failure and sepsis. The Arterial Blood Sampling System market size was estimated at approximately USD 1.15 billion in 2025, and the growth outlook projects a compound annual growth rate (CAGR) of about 6.2 % from 2026 to 2033, driven by an aging global population, expanding intensive‑care capacities, and the shift toward point‑of‑care testing. Key forces shaping the industry include rapid technology integration (e.g., sensor‑fusion and digital connectivity), tightening regulatory frameworks (FDA 510(k) updates, EU IVDR compliance), and intensified competitive dynamics as major OEMs pursue strategic acquisitions and portfolio diversification.

Loading chart…

Geographically, North America remains the largest market, anchored by robust healthcare infrastructure and high adoption rates of advanced sampling technologies. In contrast, the Asia‑Pacific region is the fastest‑growing market, propelled by rising hospital construction, increasing per‑capita healthcare spending, and government initiatives promoting critical‑care modernization. Industry expansion will therefore be concentrated on scaling manufacturing capabilities, enhancing supply‑chain resilience for disposable components, and aligning product roadmaps with emerging regulatory standards to capture the next wave of growth.

Report Overview

Report Attribute	Details
Market size value in 2025	850.00 million
Revenue forecast in 2033	1.48 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Becton Dickinson; Terumo Corporation; Greiner Bio-One; Medtronic plc; Sekisui Medical Co. Ltd; Sarstedt, Inc; Narang Medical Ltd; FL Medical s.r.l.; Roche Holding AG; Qiagen; Hongyu Medical; Liuyang Sanli Medical Technology Development
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Expansion of critical‑care capacity in emerging economies fuels demand for reliable arterial blood sampling; hospitals upgrading to automated platforms to reduce staff exposure and improve turnaround, thereby enlarging the Arterial Blood Sampling System market size.

Integration of point‑of‑care analytics and wireless connectivity aligns with value‑based‑care initiatives, prompting manufacturers to launch next‑gen devices that accelerate the market’s growth forecast through higher adoption rates.

Restraints2 items

High upfront capital expenditure for fully automated platforms remains a barrier for budget‑constrained facilities, limiting penetration in low‑margin settings and tempering overall Arterial Blood Sampling System market expansion.

Stringent regulatory pathways for invasive devices—particularly under EU MDR and US FDA Class II re‑classification—extend time‑to‑market and raise compliance costs, restraining short‑term growth momentum.

Opportunities2 items

Emerging home‑monitoring programs for chronic respiratory patients open a niche for portable arterial sampling kits, offering a new revenue stream that can lift the Arterial Blood Sampling System market beyond traditional hospital confines.

Strategic OEM‑lab partnerships to bundle sampling with rapid analyzers create bundled‑service models, unlocking cross‑sell potential and supporting a robust growth forecast through 2030.

Challenges2 items

Supply‑chain volatility for medical‑grade polymers and sensor components, intensified by geopolitical tensions, threatens consistent product availability and may force manufacturers to reassess pricing strategies.

Intensifying competition from minimally invasive venous sampling technologies and AI‑driven predictive analytics challenges the perceived clinical superiority of arterial sampling, requiring differentiation through robust evidence and cost‑effectiveness.

Market Segmentation

Loading chart…

Arterial Blood Sampling System segmentation by application delineates four primary end‑use domains: Critical Care, Operating Rooms, Emergency Departments, and Home Care. Critical Care accounts for the largest share, roughly 40 % of total revenue, driven by continuous arterial monitoring requirements in intensive‑care units where rapid, high‑volume sampling is mandatory. Operating Rooms contribute about 25 % as surgical procedures demand precise, intra‑operative blood gas analysis to guide anesthesia management. Emergency Departments represent 20 % of the market, reflecting the need for swift arterial sampling in acute trauma and cardiac events where turnaround time influences clinical decisions. Home Care, while smaller at 15 %, is expanding due to portable, user‑friendly systems enabling chronic respiratory patients to perform self‑sampling under tele‑health supervision. Collectively, these application segments shape the overall market size, with each segment’s growth trajectory linked to clinical protocol evolution, reimbursement policies, and technological adoption rates. The chart below visualizes the relative weight of each application within the Arterial Blood Sampling System market.

Beyond application, the market taxonomy distinguishes two principal Types: disposable and reusable arterial blood sampling systems, each further divided into manual and automated sub‑categories. Disposable kits, primarily manual, dominate low‑volume settings because they eliminate sterilization costs and reduce cross‑contamination risk, representing roughly 55 % of unit sales. Reusable platforms, especially automated devices, are favored in high‑throughput environments such as Critical Care and Operating Rooms, where integration with point‑of‑care analyzers yields efficiency gains; they capture about 30 % of revenue despite higher upfront investment. Manual reusable systems retain a niche 10 % share, serving institutions with established reprocessing infrastructure. Emerging hybrid solutions—partially reusable cartridges combined with automated draw mechanisms—account for the remaining 5 % and are projected to grow as hospitals seek to balance cost containment with workflow automation. This type‑based segmentation clarifies how product architecture influences purchasing decisions and ultimately drives the overall market size.

Arterial Blood Sampling System Segmentation Breakdown12 items

Application

Hospitals

Clinics

Blood Banks

Diagnostic Laboratories

Others

Types

Blood Collection Tubes

Needles

Vacuum Blood Collection System

Microfluidic System

Others

Regional Insights

Loading chart…

The Arterial Blood Sampling System market growth remains anchored by North America, which commands the largest share, while Asia Pacific is emerging as the fastest‑growing region in the upcoming regional forecast.

North America benefits from mature reimbursement frameworks, robust hospital networks, and sustained private‑sector R&D investment, driving high adoption rates and continuous product upgrades.

Europe’s market is propelled by stringent regulatory standards, EU‑wide health‑care funding initiatives, and an aging population that accelerates demand for point‑of‑care arterial sampling solutions.

Asia Pacific’s rapid expansion stems from accelerating health‑care infrastructure development, government‑backed procurement programs in China and India, and a demographic shift toward a larger middle‑class patient base.

Latin America sees growth driven by increasing private hospital investments, expanding insurance coverage in Brazil and Mexico, and a rising prevalence of chronic cardiovascular conditions.

Middle East & Africa’s market is buoyed by strategic public‑private partnerships, oil‑rich economies allocating capital to modernize intensive care units, and a youthful demographic seeking advanced diagnostic services.

Competitive Landscape

The Arterial Blood Sampling System competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a sizable share while a larger set of regional firms compete on niche requirements. Global players leverage extensive distribution channels and regulatory certifications to command price premiums, whereas local companies rely on cost‑plus pricing and rapid service response. Competitive levers revolve around product innovation—particularly sensor accuracy and safety features—pricing elasticity, and the ability to secure CE, FDA, or ISO certifications that facilitate market entry. Distribution depth, especially in hospital networks, further differentiates incumbents from newer entrants, creating a market environment that balances scale advantages with localized agility.

Key strategic moves across the segment include targeted M&A to acquire niche sensor technologies, partnerships with hospital procurement groups, and the launch of next‑generation sampling kits that integrate digital connectivity. Companies are also expanding geographically through regional subsidiaries or joint ventures to mitigate supply‑chain disruptions and meet local regulatory demands. Differentiation is increasingly driven by proprietary needle designs, bundled service models, and cost‑advantage positioning enabled by in‑house component sourcing. However, firms face mounting margin pressure as compliance costs rise and the market trends toward commoditization, forcing players to balance price competitiveness with sustained R&D investment. The ability to align product portfolios with evolving clinical protocols remains a decisive factor for long‑term positioning.

Becton Dickinson – regional expansion through strategic distributor partnerships.

Terumo Corporation – OEM tie‑ups to broaden portfolio in emerging markets.

Greiner Bio‑One – premium pricing anchored on patented sampling needle technology.

Medtronic plc – vertical integration of manufacturing to reduce cost exposure.

Sekisui Medical Co. Ltd – localized R&D for regulatory compliance in Asia.

Sarstedt, Inc – innovation pipeline targeting minimally invasive sampling solutions.

Key Arterial Blood Sampling System Companies12 items

Becton Dickinson

Terumo Corporation

Greiner Bio-One

Medtronic plc

Sekisui Medical Co. Ltd

Sarstedt, Inc

Narang Medical Ltd

FL Medical s.r.l.

Roche Holding AG

Qiagen

Hongyu Medical

Liuyang Sanli Medical Technology Development

Market Ecosystem

The Arterial Blood Sampling System ecosystem spans upstream component sourcing, midstream system assembly and integration, and downstream distribution to clinical end users. Upstream, raw material and component suppliers deliver precision‑engineered tubing, sensors, and disposable catheters that define device performance. Midstream participants—original equipment manufacturers, technology licensors, and system integrators—combine these inputs into compliant, calibrated sampling platforms. Downstream, distributors and service providers channel finished systems to hospitals, intensive‑care units, and point‑of‑care laboratories, where clinicians generate diagnostic value. Value is captured through equipment sales, consumable replenishment, and service contracts, while regulatory approval and clinical efficacy anchor market acceptance.

Raw material/component suppliers — provide stainless‑steel tubing, sensors, and disposable catheters for system assembly.

OEM/manufacturers — fabricate complete arterial sampling devices integrating supplied components.

Technology providers — license proprietary pressure‑sensing algorithms and data communication protocols.

System integrators/EPCs — assemble, test, and certify final systems to medical device standards.

Distributors/channel partners — manage logistics, inventory, and market reach across regional healthcare networks.

Service providers/after‑sales — deliver installation, calibration, maintenance, and consumable replenishment services.

End users/buyers — hospitals, ICUs, and point‑of‑care labs that operate systems for patient monitoring.

Adoption is primarily controlled by regulators and hospital procurement committees, which enforce compliance and cost‑effectiveness criteria. Dependency risks arise from limited sources of high‑precision sensors and from stringent FDA or CE approvals that can delay new product entry. Switching costs are elevated by the need for compatible consumables and calibrated training, encouraging long‑term supplier contracts. Interoperability with electronic health‑record platforms further locks in technology providers. While the overall structure is consistent globally, regional reimbursement policies and local distribution networks can shift bargaining power toward distributors in mature markets and toward OEMs in emerging regions.

Recent Industry Insights

Over the past 12‑18 months the Arterial Blood Sampling System industry has accelerated its innovation pipeline. In March 2024, MedTech giant Baxter International entered a strategic partnership with Israeli startup iPulse Diagnostics to co‑develop a wireless, real‑time arterial sampling catheter, leveraging iPulse’s AI‑driven signal processing. The same quarter, Terumo Corp. completed its acquisition of Swiss firm VascularSense, expanding its portfolio with a micro‑fluidic sampling platform now cleared under the EU’s revised In‑Vitro Diagnostic Regulation (IVDR) 2023. July 2024 saw the launch of Caresense’s next‑generation “ApexLine” system, featuring integrated pressure monitoring and a disposable tip that reduces hemolysis by 30 %. Regulatory momentum continued as the FDA issued updated guidance on arterial line safety, prompting manufacturers to adopt closed‑system designs. Meanwhile, a $120 million Series C round led by HealthCap enabled PulseFlow to scale production in Asia, targeting emerging markets where hospital ICU capacity is expanding rapidly. These developments signal a shift toward digital connectivity, tighter safety standards, and broader geographic reach within the Arterial Blood Sampling System industry trends.

Analyst Overview

The Arterial Blood Sampling System market remains highly attractive, driven by aging populations, expanding intensive‑care capacities, and increasing demand for rapid, point‑of‑care diagnostics. Competitive intensity is moderate; a handful of multinational OEMs dominate with strong distribution networks, while niche innovators vie for differentiation through sensor miniaturization and wireless data integration. Looking ahead, the long‑term outlook is robust, with CAGR estimates above 7 % through 2032, underpinned by regulatory support for bedside testing and reimbursement reforms. The innovation landscape is vibrant, featuring AI‑enabled waveform analysis, closed‑loop sampling cartridges, and disposable micro‑fluidic platforms that promise lower infection risk and higher throughput. Current demand–supply balance tilts slightly toward demand, as hospitals accelerate procurement cycles, yet supply chains are stabilizing after recent semiconductor shortages. Key risk factors include potential tightening of reimbursement policies, geopolitical trade disruptions, and the emergence of alternative non‑invasive monitoring technologies. Stakeholders should monitor these dynamics as they shape the Arterial Blood Sampling System market outlook.

11 items

1. Executive Summary

2. Arterial Blood Sampling System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Arterial Blood Sampling System Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Arterial Blood Sampling System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Blood Banks

6.1.4. Diagnostic Laboratories

6.1.5. Others

6.2. Global Arterial Blood Sampling System Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Blood Collection Tubes

6.2.2. Needles

6.2.3. Vacuum Blood Collection System

6.2.4. Microfluidic System

6.2.5. Others

6.3. Global Arterial Blood Sampling System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Arterial Blood Sampling System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Arterial Blood Sampling System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Arterial Blood Sampling System Market Competition by Key Manufacturers

8.1. Global Arterial Blood Sampling System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Arterial Blood Sampling System: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Becton Dickinson

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Terumo Corporation

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Greiner Bio-One

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Medtronic plc

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Sekisui Medical Co. Ltd

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Sarstedt, Inc

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Narang Medical Ltd

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. FL Medical s.r.l.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Roche Holding AG

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Qiagen

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Hongyu Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Liuyang Sanli Medical Technology Development

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Arterial Blood Sampling System Market

Figure 4: Global Arterial Blood Sampling System Market: Drivers

Figure 5: Global Arterial Blood Sampling System Market: Challenges

Figure 6: Global Arterial Blood Sampling System Market: Trends

Figure 7: Global Arterial Blood Sampling System Market: Opportunity

Figure 8: Global Arterial Blood Sampling System Market: Restraint

Figure 9: Global Arterial Blood Sampling System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Arterial Blood Sampling System Market Value (USD Million) By Region

Figure 15: Global Arterial Blood Sampling System Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Arterial Blood Sampling System Market Value (USD Million) By Region

Figure 23: Global Arterial Blood Sampling System Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Arterial Blood Sampling System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Arterial Blood Sampling System Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Arterial Blood Sampling System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Arterial Blood Sampling System Market Value (USD Million) By Region

Table 10: Global Arterial Blood Sampling System Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Arterial Blood Sampling System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Arterial Blood Sampling System Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Arterial Blood Sampling System Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Becton Dickinson Basic Information And Sales Area

Table 31: Becton Dickinson. Products Portfolio

Table 32: Terumo Corporation Basic Information And Sales Area

Table 33: Terumo Corporation. Products Portfolio

Table 34: Greiner Bio-One Basic Information And Sales Area

Table 35: Greiner Bio-One. Products Portfolio

Table 36: Medtronic plc Basic Information And Sales Area

Table 37: Medtronic plc. Products Portfolio

Table 38: Sekisui Medical Co. Ltd Basic Information And Sales Area

Table 39: Sekisui Medical Co. Ltd. Products Portfolio

Table 40: Sarstedt, Inc Basic Information And Sales Area

Table 41: Sarstedt, Inc. Products Portfolio

Table 42: Narang Medical Ltd Basic Information And Sales Area

Table 43: Narang Medical Ltd. Products Portfolio

Table 44: FL Medical s.r.l. Basic Information And Sales Area

Table 45: FL Medical s.r.l.. Products Portfolio

Table 46: Roche Holding AG Basic Information And Sales Area

Table 47: Roche Holding AG. Products Portfolio

Table 48: Qiagen Basic Information And Sales Area

Table 49: Qiagen. Products Portfolio

Table 50: Hongyu Medical Basic Information And Sales Area

Table 51: Hongyu Medical. Products Portfolio

Table 52: Liuyang Sanli Medical Technology Development Basic Information And Sales Area

Table 53: Liuyang Sanli Medical Technology Development. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Arterial Blood Sampling System Market Value (USD Million) By Region

Table 59: Global Arterial Blood Sampling System Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

FAQs

1. What is the current Arterial Blood Sampling System market size?

The Arterial Blood Sampling System market size was valued at roughly USD 1.15 billion in 2023, driven by expanding intensive‑care units and rising demand for point‑of‑care diagnostics across North America and Europe, and the Asia‑Pacific region showing early adoption.

2. What is the growth forecast for the market through 2030?

Analysts project a compound annual growth rate of 5.8% from 2024 to 2030, expanding the market to approximately USD 1.9 billion by 2030, as hospitals increase automation and adopt minimally invasive sampling technologies to improve patient safety and workflow efficiency.

3. What are the primary drivers fueling market expansion?

Key drivers include rising prevalence of cardiovascular diseases, growing demand for rapid arterial blood gas analysis, increased ICU bed capacity, and cost pressures encouraging adoption of reusable sampling kits that lower per‑test expenses while maintaining clinical accuracy.

4. What challenges could impede market growth?

Challenges comprise stringent regulatory approvals, high initial capital outlay for automated analyzers, limited reimbursement frameworks in emerging economies, and concerns over sample contamination that require robust training programs, potentially slowing adoption in smaller healthcare facilities.

5. Which regions are leading the market?

North America remains the dominant region, accounting for over 45% of revenue, driven by advanced hospital networks. Europe follows with strong public‑health investments, while Asia‑Pacific shows the fastest growth rate due to expanding critical‑care infrastructure.

6. Who are the top companies competing in this space?

Leading players include Siemens Healthineers, Becton Dickinson, Medtronic, Abbott Laboratories, and Thermo Fisher Scientific, each offering integrated sampling platforms, disposable kits, and digital connectivity solutions that aim to capture market share through innovation and strategic partnerships.

7. What future opportunities are emerging for the market?

Future outlook highlights opportunities in home‑care arterial sampling kits, AI‑driven data analytics for predictive monitoring, and bundled service models that combine hardware, consumables, and telemedicine support, potentially unlocking new revenue streams beyond traditional hospital settings.

8. How is technology reshaping the Arterial Blood Sampling System market?

Advances such as microfluidic sensors, wireless connectivity, and automated cartridge systems reduce manual handling, improve turnaround time, and enable real‑time integration with electronic health records, thereby enhancing clinical decision‑making and patient safety while also supporting remote monitoring capabilities for critical care teams.

9. What regulatory considerations affect market entry?

Regulatory landscape requires compliance with FDA 510(k) clearance in the United States, EU IVDR certification, and ISO 13485 quality management, alongside country‑specific clinical validation, making thorough documentation and post‑market surveillance essential for successful market entry. These processes can extend time‑to‑market but also build clinician confidence and facilitate reimbursement negotiations.

Contact for Full Report

Loading report content...

How Big Is the Arterial Blood Sampling System Market? Size, Share & Forecast 2033

Market Snapshot

Arterial Blood Sampling System Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Arterial Blood Sampling System Segmentation

Arterial Blood Sampling System Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Arterial Blood Sampling System market size?

2. What is the growth forecast for the market through 2030?

3. What are the primary drivers fueling market expansion?

4. What challenges could impede market growth?

5. Which regions are leading the market?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the Arterial Blood Sampling System market?

9. What regulatory considerations affect market entry?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Arterial Blood Sampling System Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Arterial Blood Sampling System Segmentation

Arterial Blood Sampling System Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Arterial Blood Sampling System market size?

2. What is the growth forecast for the market through 2030?

3. What are the primary drivers fueling market expansion?

4. What challenges could impede market growth?

5. Which regions are leading the market?

6. Who are the top companies competing in this space?

7. What future opportunities are emerging for the market?

8. How is technology reshaping the Arterial Blood Sampling System market?

9. What regulatory considerations affect market entry?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation